Revvity, Inc. (NYSE: RVTY), a provider of health science solutions and technologies, on Monday reported an increase in revenue and adjusted profit
Earnings Summary: Revvity (RVTY) reports higher revenue and earnings for Q1 2025
Categories
Medical Devices
Earnings: Intuitive Surgical (ISRG) reports higher revenue and profit for Q1 2025
Healthcare technology company Intuitive Surgical Inc. (NASDAQ: ISRG) Wednesday reported a sharp increase in revenue and adjusted earnings for the first quarter
Earnings: Highlights of Thermo Fisher Scientific’s (TMO) Q1 2025 report
Thermo Fisher Scientific Inc. (NYSE: TMO) on Wednesday announced financial results for the first quarter of 2025, reporting a modest increase in
AngioDynamics (ANGO) Q3 2025 loss narrows; sales down 4%
Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO) Wednesday reported a narrower net loss for the third quarter of 2025. Revenues decreased by
Earnings Summary: Highlights of CooperCompanies (COO) Q1 2025 results
Medical device maker CooperCompanies (NYSE: COO) has announced financial results for the first quarter of 2025, reporting an increase in revenues and
MDT Earnings: Medtronic reports higher Q3 2025 revenue and adj. profit
Medical device maker Medtronic plc (NYSE: MDT) on Tuesday reported an increase in revenues and adjusted profit for the third quarter of
Earnings Summary: Highlights of IDEXX’s Q4 2024 report
Medical device company IDEXX Laboratories, Inc. (NASDAQ: IDXX) on Monday reported higher revenues and net income for the fourth quarter of 2024.
Intuitive Surgical (ISRG) Earnings: 4Q24 Key Numbers
Intuitive Surgical Inc. (NASDAQ: ISRG) reported revenue of $2.41 billion for the fourth quarter of 2024, up 25% from the same period
Important takeaways from Abbott Laboratories’ Q4 2024 earnings report
Abbott Laboratories (NYSE: ABT) reported mixed results for the final months of fiscal 2024 and issued guidance for the first quarter and
Highlights of Abbott Laboratories (ABT) Q4 2024 results
Abbott Laboratories (NYSE: ABT) on Wednesday announced financial results for the fourth quarter of 2024, reporting an increase in sales and adjusted
Johnson & Johnson (JNJ) likely to report mixed results for Q4 2024
Johnson & Johnson (NYSE: JNJ) is set to publish its December-quarter report on January 22, amid expectations for mixed results. The company,
Earnings Summary: A snapshot of CooperCompanies (COO) Q4 2024 results
Medical device maker CooperCompanies (NYSE: COO) has announced financial results for the fourth quarter of 2024, reporting an increase in revenues and
MDT Earnings: Highlights of Medtronic’s Q2 2025 financial results
Medical device maker Medtronic plc (NYSE: MDT) reported a modest increase in revenues and adjusted profit for the second quarter of 2025.
Earnings Summary: Baxter International reports higher sales for Q3 2024
Medical device maker Baxter International Inc. (NYSE: BAX) announced financial results for the third quarter of 2024, reporting a modest increase in
Earnings Summary: Thermo Fisher Scientific (TMO) reports Q3 2024 results
Thermo Fisher Scientific Inc. (NYSE: TMO) on Wednesday reported financial results for the third quarter of 2024. The company also issued full-year
Intuitive Surgical (ISRG) reports double-digit growth in Q3 revenue and earnings
Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) has reported a sharp increase in earnings for the third quarter of 2024, reflecting
Earnings Preview: Johnson & Johnson bets on innovation to stay in growth mode
Over the years, Johnson & Johnson (NYSE: JNJ) has remained a dominant player in the medical industry, benefitting from its unique business
ANGO Earnings: A snapshot of AngioDynamics’ Q1 2025 results
AngioDynamics Inc. (NASDAQ: ANGO) Thursday reported a net loss for the first quarter of 2025. The medical device company's revenues decreased by
Medtronic bets on innovation and new technology to drive long-term growth
Over the years, Medtronic plc (NYSE: MDT) has constantly strengthened its position in the medical device industry by innovating the product portfolio
Medtronic (MDT) reports higher revenue and profit for Q1 2025
Medical device maker Medtronic plc (NYSE: MDT) reported an increase in revenues and adjusted profit for the first quarter of 2025. First-quarter
Earnings Summary: A snapshot of Bio-Techne’s (TECH) Q4 2024 results
Biotechnology company Bio-Techne Corporation (NASDAQ: TECH) on Wednesday announced financial results for the fourth quarter of 2024, reporting a decline in profit.